首页 | 本学科首页   官方微博 | 高级检索  
     


Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study
Authors:Bourhis Jean-Henri,Bouko Yasmina,Koscielny Serge,Bakkus Marleen,Greinix Hildegard,Derigs Gunter,Salles Gilles,Feremans Walter,Apperley Jane,Samson Diana,Björkstrand Bo,Niederwieser Dietger,Gahrton Gösta,Pico José-Luis,Goldschmidt Hartmut  European Group for Blood  Marrow Transplantation
Affiliation:Division of Hematology, Department of Medicine, Institut Gustave Roussy, 94800 Villejuif, France. jhb@igr.fr
Abstract:
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号